Clinical Trial

Autologous Stem Cell Transplantation for Crohn's Disease

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The objective of this study is to evaluate the safety and effectiveness of administering high-dose chemotherapy followed by infusion of autologous CD34-selected peripheral blood stem cells (PBSC) in pediatric and adult patients with severe Crohn's disease.
Protocol Amendment History 31 amendments
This ClinicalTrials.gov record has been amended 31 times since 2008-06-05; most recent amendment 2025-12-08.
Status change: Not Yet Recruiting → Recruiting 2012-01-06
Status change: Recruiting → Not Yet Recruiting 2011-09-08
Trial Details
NCT Number NCT00692939
Lead Sponsor Paul Szabolcs
Conditions Crohn's Disease
Enrollment 20 participants
Start Date 2012-06-26
Primary Completion 2026-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-15